DK0768083T3 - Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt - Google Patents

Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt

Info

Publication number
DK0768083T3
DK0768083T3 DK96304906T DK96304906T DK0768083T3 DK 0768083 T3 DK0768083 T3 DK 0768083T3 DK 96304906 T DK96304906 T DK 96304906T DK 96304906 T DK96304906 T DK 96304906T DK 0768083 T3 DK0768083 T3 DK 0768083T3
Authority
DK
Denmark
Prior art keywords
sertraline
myocardial infarction
post myocardial
treat patients
patients
Prior art date
Application number
DK96304906T
Other languages
English (en)
Inventor
Brian F Johnson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0768083T3 publication Critical patent/DK0768083T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96304906T 1995-07-17 1996-07-03 Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt DK0768083T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US143795P 1995-07-17 1995-07-17

Publications (1)

Publication Number Publication Date
DK0768083T3 true DK0768083T3 (da) 2003-06-23

Family

ID=21696010

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96304906T DK0768083T3 (da) 1995-07-17 1996-07-03 Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt

Country Status (15)

Country Link
EP (1) EP0768083B1 (da)
JP (1) JPH0930959A (da)
KR (1) KR970005283A (da)
CN (1) CN1147937A (da)
AT (1) ATE235237T1 (da)
AU (1) AU721967B2 (da)
CA (1) CA2181225C (da)
DE (1) DE69626916T2 (da)
DK (1) DK0768083T3 (da)
ES (1) ES2192217T3 (da)
IL (1) IL118833A (da)
MY (1) MY117638A (da)
NZ (1) NZ299006A (da)
PT (1) PT768083E (da)
ZA (1) ZA966027B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU724635B2 (en) * 1997-07-01 2000-09-28 Pfizer Products Inc. Gelatine encapsulated solution dosage forms of sertraline
WO1999001121A1 (en) 1997-07-01 1999-01-14 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
GB9714841D0 (en) * 1997-07-14 1997-09-17 Smithkline Beecham Plc Treatment method
WO2000021521A2 (en) * 1998-10-13 2000-04-20 Pfizer Products Inc. Sertraline oral concentrate
US6727283B2 (en) * 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
GB0814466D0 (en) * 2008-08-07 2008-09-10 Rosemont Pharmaceuticals Ltd Sertraline composition
US20220265579A1 (en) * 2019-05-15 2022-08-25 Vasthera Co. Ltd. Composition for preventing or treating cardio-cerebrovascular disease comprising autophagy activator as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms

Also Published As

Publication number Publication date
ES2192217T3 (es) 2003-10-01
EP0768083A3 (en) 1999-12-01
EP0768083A2 (en) 1997-04-16
AU721967B2 (en) 2000-07-20
EP0768083B1 (en) 2003-03-26
IL118833A (en) 2000-07-26
CA2181225A1 (en) 1997-01-18
CA2181225C (en) 1999-03-23
AU6053496A (en) 1997-01-23
DE69626916T2 (de) 2003-10-09
PT768083E (pt) 2003-08-29
CN1147937A (zh) 1997-04-23
JPH0930959A (ja) 1997-02-04
DE69626916D1 (de) 2003-04-30
KR970005283A (ko) 1997-02-19
MY117638A (en) 2004-07-31
ATE235237T1 (de) 2003-04-15
IL118833A0 (en) 1996-10-31
NZ299006A (en) 2000-08-25
ZA966027B (en) 1998-01-16

Similar Documents

Publication Publication Date Title
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
KR960702318A (ko) 근육 질병 및 장애의 치료방법
DK1346041T3 (da) Terapeutiske midler og fremgangsmåder til anvendelse deraf til behandling af en amyloidogen sygdom
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
MY106075A (en) A method of treating anxiety-related disorders using sertraline.
DK0687176T3 (da) Anvendelse af riluzol til behandling af AIDS-relaterede nervesygdomme
DK0768083T3 (da) Anvendelse af sertralin til at behandle patienter med post myocardisk infarkt
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
SE9302218D0 (sv) New use
HU905683D0 (en) The treatment of drug dependence by using sertraline
DE69621786D1 (de) Aminotetralinderivat zur behandlung von herzkreislauferkrankung
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.
SE9501773D0 (sv) New use
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
MX9701528A (es) Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.
RU99118112A (ru) Способ лечения больных с невротическими расстройствами препаратом "миелопид"